Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) Long-Term Debt Issuances (2016 - 2025)

Bio-Techne has reported Long-Term Debt Issuances over the past 10 years, most recently at $66.0 million for Q2 2025.

  • For Q2 2025, Long-Term Debt Issuances changed N/A year-over-year to $66.0 million; the TTM value through Jun 2025 reached $104.0 million, down 53.78%, while the annual FY2025 figure was $104.0 million, 53.78% down from the prior year.
  • Long-Term Debt Issuances for Q2 2025 was $66.0 million at Bio-Techne, up from $38.0 million in the prior quarter.
  • Over five years, Long-Term Debt Issuances peaked at $449.7 million in Q3 2022 and troughed at $10.0 million in Q3 2021.
  • A 4-year average of $129.5 million and a median of $65.5 million in 2023 define the central range for Long-Term Debt Issuances.
  • Biggest five-year swings in Long-Term Debt Issuances: soared 4396.61% in 2022 and later plummeted 64.42% in 2023.
  • Year by year, Long-Term Debt Issuances stood at $40.0 million in 2021, then soared by 1024.15% to $449.7 million in 2022, then crashed by 85.54% to $65.0 million in 2023, then rose by 1.54% to $66.0 million in 2025.
  • Business Quant data shows Long-Term Debt Issuances for TECH at $66.0 million in Q2 2025, $38.0 million in Q1 2025, and $65.0 million in Q4 2023.